Skip to main content
ZEVRA THERAPEUTICS, INC. logo

ZEVRA THERAPEUTICS, INC. — Investor Relations & Filings

Ticker · ZVRA ISIN · US4884452065 LEI · 254900CU6T74V18Y1W18 US Manufacturing
Filings indexed 830 across all filing types
Latest filing 2019-05-23 Delisting Announcement
Country US United States of America
Listing US ZVRA

About ZEVRA THERAPEUTICS, INC.

https://zevra.com/

Zevra Therapeutics, Inc. is a commercial-stage biopharmaceutical company dedicated to developing and commercializing therapies for patients with rare diseases. The company focuses on addressing significant unmet medical needs by combining a data-driven scientific approach with a patient-first perspective. Its portfolio includes commercial products such as MIPLYFFA®, an FDA-approved treatment for Niemann-Pick disease type C (NPC), and OLPRUVA®. Zevra Therapeutics also maintains a late-stage clinical pipeline, specializing in advancing promising medicines that face complex clinical and regulatory challenges for conditions with limited or no available treatments.

Recent filings

Filing Released Lang Actions
FORM 8-K
Delisting Announcement Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated May 23, 2019, reporting a notice from NASDAQ regarding the company's non-compliance with listing rules due to market value falling below the required threshold. The document discusses the potential delisting process and options for the company but does not contain financial statements or detailed financial data. It is an official notice about a delisting risk and related compliance matters. Given the content and the nature of the filing, this fits the category of a Delisting Announcement (DLST). The document length is 5384 characters, sufficient to provide substantive detail about the delisting notice rather than a brief announcement. Therefore, the classification is DLST with high confidence.
2019-05-23 English
FORM 4
Director's Dealing
2019-05-15 English
FORM 4
Director's Dealing
2019-05-15 English
FORM 4
Director's Dealing
2019-05-15 English
FORM 4
Director's Dealing
2019-05-15 English
FORM 4
Director's Dealing
2019-05-15 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.